Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hubbard

Showing results (441-450 of 562) with videos related to

Pageof 57
Sort By:
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 27, 2021
Molecular characterisation of the first New Delhi metallo-β-lactamase 1-producing Acinetobacter baumannii from TanzaniaSabrina J Moyo, Joel Manyahi, Alasdair T M Hubbard, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1985
Immunoassay for IgG rheumatoid factor with a murine monoclonal anti-Fd antibodyJ S McDougal, M S Kennedy, M Hubbard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 19, 2023
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent mannerSung M Yang, Ayan Ghoshal, Jeffrey M Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapyD L Longo, P L Duffey, E S Jaffe, et al.
The Oncologist|June 6, 2019
A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal CancerMohamad Bassam Sonbol, Raed Benkhadra, Zhen Wang, et al.
Nursing Research|June 2, 2026
Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous MelanomaCarolyn S Harris, Katy K Tsai, Lauren Liu, et al.
Cancer Research|January 1, 1981
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancerR B Jones, J M Collins, C E Myers, et al.
Head & Neck|July 25, 2017
Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivorsRyan P Goepfert, C David Fuller, G Brandon Gunn, et al.
JAMA Network Open|February 22, 2023
Association Between Survival and Metastatic Site in Mismatch Repair-Deficient Metastatic Colorectal Cancer Treated With First-line PembrolizumabBahar Saberzadeh-Ardestani, Jeremy C Jones, Joleen M Hubbard, et al.
Pageof 57

Showing results (441-450 of 562) with videos related to

Sort By:
Pageof 57
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 27, 2021
Molecular characterisation of the first New Delhi metallo-β-lactamase 1-producing Acinetobacter baumannii from TanzaniaSabrina J Moyo, Joel Manyahi, Alasdair T M Hubbard, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1985
Immunoassay for IgG rheumatoid factor with a murine monoclonal anti-Fd antibodyJ S McDougal, M S Kennedy, M Hubbard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 19, 2023
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent mannerSung M Yang, Ayan Ghoshal, Jeffrey M Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapyD L Longo, P L Duffey, E S Jaffe, et al.
The Oncologist|June 6, 2019
A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal CancerMohamad Bassam Sonbol, Raed Benkhadra, Zhen Wang, et al.
Nursing Research|June 2, 2026
Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous MelanomaCarolyn S Harris, Katy K Tsai, Lauren Liu, et al.
Cancer Research|January 1, 1981
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancerR B Jones, J M Collins, C E Myers, et al.
Head & Neck|July 25, 2017
Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivorsRyan P Goepfert, C David Fuller, G Brandon Gunn, et al.
JAMA Network Open|February 22, 2023
Association Between Survival and Metastatic Site in Mismatch Repair-Deficient Metastatic Colorectal Cancer Treated With First-line PembrolizumabBahar Saberzadeh-Ardestani, Jeremy C Jones, Joleen M Hubbard, et al.
Pageof 57